Investments in digital therapeutics grew nearly three-fold in 2021 from 2020. Meanwhile VC dollars are also pouring into AI, psychedelics as well as faith-based for-profit apps, which attracted $175.3 million in venture funding in 2021. What’s the efficacy of these new tools and treatments?

Panel: Ben Lewis, co-founder and CEO, Limbix; Nanea Reeves, founder and CEO, Tripp, Mainul Mondal, Founder & CEO, Ellipsis Health.